Stio Life Science Is An Egyptian Family Owned Private Joint Stock Company Founded In 2016With An Authorized Capital Of Egp 500 Millionit Specializes In Advanced Therapies For Cardiovascular Healthrespiratory Caresedationand Pain Managementthe Company Is Dedicated To Localizing The Production Of High Quality Pharmaceuticals To Meet Healthcare Needs In Egyptafricaand The Middle East Stio Life Science Is Focused On Developing Innovative Pharmaceutical Solutions And Plans To Produce Around 60 Products By 2030Targeting Areas Such As Heart Disease And Critical Careadditionallythrough Its Subsidiarywadi El Nile Stio Life Sciencethe Company Manufactures Medical Devices For Renal Dialysisaiming To Provide Cost Effective Solutions For Healthcare Providers Globallystio Life Science Has Made Significant Investments To Enhance Local Pharmaceutical Production And Improve Accessibility To Effective Treatments
